Comparative genomic hybridization-based oncogenetic tree model for genetic classification of breast cancer.
OBJECTIVE
To describe a genetic progression pathway in breast cancer by a maximum likelihood-based tree model representing the dependencies between chromosomal imbalances.


METHODS
One hundred six cases were studied by comparative genomic hybridization, followed by maximum likelihood estimation of an oncogenetic tree model.


RESULTS
The tree model identified 3 clusters with correlated chromosomal imbalances. The first cluster included losses at 4q, 5q, 6q, 9p, 13q and a gain at 17q; the second cluster included gains at 1q, 8q, 16p and 20q; the third cluster included losses at 8p, 11q, 16q and 18q. The imbalances nearest the root of the tree were the loss at 13q (cluster 1), the gain at 1q (cluster 2) and the loss at 18q (cluster 3), reflecting an early change in breast cancer evolution. Cox regression analysis revealed the tumor stage and the grade as relevant for overall survival (p = 0.001) and the tumor stage, the grade and the loss at 16q as relevant for disease-free survival (p = 0.001).


CONCLUSIONS
Methods like oncogenetic tree analysis provide insights into the genetic progression of breast cancer and may extract relevant markers detected by screening methods like comparative genomic hybridization for further studies.
Friedrich
Katrin
K
Institute of Pathology, University Hospital "Carl Gustav Carus" Dresden, Germany. katrin.friedrich@uniklinikum-dresden.de
von Heydebreck
Anja
A
Haroske
Gunter
G
Scheithauer
Jens
J
Meyer
Wolfdietrich
W
Kunze
Klaus Dietmar
KD
Baretton
Gustavo
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000145:classification* / Q000235:genetics* / Q000473:pathology; D002869:Chromosome Aberrations; D002877:Chromosomes, Human; D055028:Comparative Genomic Hybridization; D018450:Disease Progression; D005260:Female; D006801:Humans; D008875:Middle Aged; D008957:Models, Genetic; D015233:Models, Statistical; D009367:Neoplasm Staging; D012044:Regression Analysis
D014408:Biomarkers, Tumor